Pleased to share the launch of Doalis Strategy, co-founded with Faik Somer and Bahadır Özazar.
Doalis Strategy is a senior-level strategic advisory platform focused on value creation for pharmaceutical companies operating in complex, global environments.
We work with shareholders, boards, and executive leadership teams at moments when portfolio clarity, capital allocation, and strategic transactions directly define enterprise value.
Doalis Strategy operates outside traditional consulting models.
We don’t sell frameworks or scale teams.
We focus on strategic clarity, capital discipline, and measurable outcomes.
The pharmaceutical industry today is no longer challenged by growth alone,
it is challenged by focus, coherence, and disciplined capital deployment.
Doalis Strategy exists to help companies make fewer decisions – and make them count.